Total Assets (Quarterly) Chart

View Total Assets (Quarterly) for MNOV.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Assets (Quarterly) Chart
Start Trial

Historical Total Assets (Quarterly) Data

View and export this data back to 2004. Start Trial.
Date Value
June 30, 2026 40.43M
March 31, 2026 42.70M
December 31, 2025 45.60M
September 30, 2025 47.58M
June 30, 2025 49.82M
March 31, 2025 52.43M
December 31, 2024 55.88M
September 30, 2024 58.12M
June 30, 2024 60.40M
March 31, 2024 62.89M
December 31, 2023 66.27M
September 30, 2023 68.14M
June 30, 2023 68.72M
March 31, 2023 71.13M
December 31, 2022 74.15M
September 30, 2022 78.39M
June 30, 2022 81.24M
March 31, 2022 84.18M
December 31, 2021 87.41M
September 30, 2021 91.62M
June 30, 2021 93.68M
March 31, 2021 96.10M
December 31, 2020 75.42M
September 30, 2020 77.29M
June 30, 2020 75.84M
Date Value
March 31, 2020 77.01M
December 31, 2019 79.21M
September 30, 2019 78.22M
June 30, 2019 77.15M
March 31, 2019 78.55M
December 31, 2018 77.22M
September 30, 2018 77.28M
June 30, 2018 79.08M
March 31, 2018 78.66M
December 31, 2017 43.42M
September 30, 2017 40.11M
June 30, 2017 38.46M
March 31, 2017 37.42M
December 31, 2016 39.81M
September 30, 2016 40.78M
June 30, 2016 42.36M
March 31, 2016 43.86M
December 31, 2015 37.91M
September 30, 2015 39.59M
June 30, 2015 24.72M
March 31, 2015 25.47M
December 31, 2014 27.27M
September 30, 2014 27.79M
June 30, 2014 29.56M
March 31, 2014 31.22M

Total Assets Definition

Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.

Read full definition.

Total Assets (Quarterly) Range, Past 5 Years

View Total Assets (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Assets (Quarterly) Benchmarks

View Total Assets (Quarterly) Benchmarks
Start Trial
ACADIA Pharmaceuticals, Inc. 1.743B
Alnylam Pharmaceuticals, Inc. 5.559B
Anika Therapeutics, Inc. 183.47M
Savara, Inc. 192.14M
Vericel Corp. 502.87M

Total Assets (Quarterly) Related Metrics